Details of the Drug Combinations

General Information of This Drug (ID: DM3PSUF)

Drug Name

MK-3102 DM3PSUF

Synonyms

Omarigliptin

Indication

Disease Entry	ICD 11	Status	REF
Type-2 diabetes	5A11	Phase 3	[1]
------------------------------------------------------------------------------------

Drug Type

Small molecular drug

Structure

3D MOL

2D MOL

List of Combinatorial Drugs (CBD) Containing This Drug

2 Clinical Trial Drug Combination(s) Consisting of This drug

DrugCom Name	DrugCom ID	Component Drug	Indication	REF
MK-3102 + Glimepiride	DCH06VR	Glimepiride	Type 2 Diabetes Mellitus	[2]
MK-3102 + Metformin	DC7P5T6	Metformin	Diabetes Mellitus	[3]
------------------------------------------------------------------------------------

References

1	URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 8402).
2	ClinicalTrials.gov (NCT01704261) Addition of Omarigliptin (MK-3102) to Participants With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control on Combination Therapy With Glimepiride and Metformin (MK-3102-022)
3	ClinicalTrials.gov (NCT01814748) A Study of the Safety and Efficacy of Omarigliptin (MK-3102) in ?8 and <45 Year-Old Participants With Type 2 Diabetes Mellitus and Inadequate Glycemic Control (MK-3102-028)